Macronix International Balance Sheet Health
Financial Health criteria checks 3/6
Macronix International has a total shareholder equity of NT$43.9B and total debt of NT$27.2B, which brings its debt-to-equity ratio to 61.9%. Its total assets and total liabilities are NT$79.1B and NT$35.2B respectively.
Key information
61.9%
Debt to equity ratio
NT$27.18b
Debt
| Interest coverage ratio | n/a |
| Cash | NT$12.62b |
| Equity | NT$43.91b |
| Total liabilities | NT$35.15b |
| Total assets | NT$79.07b |
Recent financial health updates
Recent updates
Investors Aren't Buying Macronix International Co., Ltd.'s (TWSE:2337) Revenues
Mar 24
Macronix International Co., Ltd.'s (TWSE:2337) Intrinsic Value Is Potentially 25% Below Its Share Price
Feb 13Macronix International Co., Ltd.'s (TWSE:2337) Share Price Is Matching Sentiment Around Its Revenues
Oct 28Macronix International Co., Ltd. (TWSE:2337) Analysts Are Pretty Bullish On The Stock After Recent Results
Aug 04Is Macronix International (TWSE:2337) A Risky Investment?
Jul 19Macronix International's (TWSE:2337) Dividend Will Be Reduced To NT$0.50
Jun 13Macronix International Co., Ltd.'s (TWSE:2337) Business And Shares Still Trailing The Industry
Jun 04Financial Position Analysis
Short Term Liabilities: 2337's short term assets (NT$30.3B) exceed its short term liabilities (NT$10.4B).
Long Term Liabilities: 2337's short term assets (NT$30.3B) exceed its long term liabilities (NT$24.7B).
Debt to Equity History and Analysis
Debt Level: 2337's net debt to equity ratio (33.1%) is considered satisfactory.
Reducing Debt: 2337's debt to equity ratio has increased from 41.8% to 61.9% over the past 5 years.
Debt Coverage: 2337's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 2337's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/03 13:52 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Macronix International Co., Ltd. is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dai Shen | BofA Global Research |
| null null | Capital Securities Corporation |
| Jay Defibaugh | CLSA |